Trial intelligence / Profile preview

Imatinib After Induction Therapy in Elderly Patients With Ph+ ALL

NCT00149136Phase 2Unknown

Sponsor
Hospices Civils de Lyon
Start
Aug 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Hospices Civils de Lyon. Status: unknown.

02

Drugs

03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on NCT00149136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00149136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call